USC Study Finds 2,000-mg Fish Oil Fails to Boost Cognition in 365 Older Adults
Updated
Updated · SciTechDaily · Jul 4
USC Study Finds 2,000-mg Fish Oil Fails to Boost Cognition in 365 Older Adults
3 articles · Updated · SciTechDaily · Jul 4
Summary
365 adults ages 55 to 80 at elevated Alzheimer’s risk showed no memory or cognitive gains after two years on daily 2,000-mg DHA fish oil supplements versus placebo.
A 17% rise in DHA levels in cerebrospinal fluid after six months showed the omega-3 reached the brain, but brain scans still found no protection against hippocampal shrinkage.
47% of participants carried the APOE4 gene, and the randomized, double-blind, placebo-controlled trial focused on people who rarely ate fish, a major natural omega-3 source.
USC researchers said the results suggest brain health may depend less on standalone supplements and more on how aging brains use nutrients within broader diet, health, and lifestyle patterns.
If high-dose fish oil fails, what is the new key to protecting your aging brain?
Is your daily fish oil supplement actually accelerating cognitive decline?
2026 Study Finds No Cognitive Benefit from High-Dose Fish Oil in Alzheimer’s Risk: Rethinking Omega-3 Supplementation
Overview
A major clinical trial led by Keck Medicine of USC, published in June 2026, has challenged the long-standing belief that fish oil supplements boost brain health. Despite years of promotion for omega-3s as a remedy for cognitive decline, the study—supported by leading health organizations—found that high-dose fish oil does not improve cognition in older adults at risk for Alzheimer’s disease. This rigorous research suggests that the benefits of fish oil supplements have been overstated, prompting a re-evaluation of their role in brain health and highlighting the need for decisions based on strong scientific evidence.